Clinical Trial

Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy

Study acronym: POLYPHEM
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is designed to find out if it is safe to keep taking blood-thinning medicine during the removal of polyps from the colon or rectum. It includes patients who regularly take blood thinners and need an elective colonoscopy. The main goal is to see how often patients have serious bleeding after the polyp removal within 30 days. The study is being done in several hospitals, and doctors evaluating the results do not know which treatment patients receive.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-17.
Trial Details
NCT Number NCT07185295
Lead Sponsor Outcomes'10
Conditions Anticoagulated Patients
Enrollment 481 participants
Start Date 2024-10-18
Primary Completion 2026-11-18 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-24